Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine 5/7 Days vs Standard in Metastatic Breast Cancer
NCT00324610Phase 2Unknown
- Sponsor
- ARTIC
- Start
- Mar 2006
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in breast cancer, sponsored by ARTIC. Status: unknown.
02
Drugs
capecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00324610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00324610.